DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment
Firm News | less than 1 min read | 12.06.21
San Francisco – December 6, 2021: Crowell & Moring represented BayWa Venture GmbH, the investment and collaboration arm of BayWa AG (BYW:Xetra) in its investment in the Israeli start-up YoFix Probiotics’ $3.5 million second financing round. YoFix Probiotics produces alternatives to milk and dairy products such as yogurt and porridge, using oats, lentils, sunflower seeds, sesame and coconut in place of milk. YoFix Probiotics is BayWa Venture’s third investment in the field of alternative proteins so far this year. The transaction was led by senior counsel Mark Kass (Washington) with support from partner Jon O’Connell (San Francisco) and counsel Matt Pelnar (San Francisco).
Insights
Firm News | 2 min read | 05.13.26
Crowell & Moring Opens Office in Minneapolis
Washington – May 13, 2026: Crowell & Moring has opened a new office in Minneapolis, Minnesota, with a focus on the firm’s regulatory, enforcement and litigation strengths in areas including health care, antitrust and competition, and labor and employment. The office launches with an initial team of eight attorneys, including partners Toni Michelle Jackson and Jeff Gleason, with additional growth anticipated in the near term. Minneapolis is Crowell’s 13th office and follows office openings last year in Boston and Dallas.
Firm News | 2 min read | 04.30.26
Crowell & Moring Celebrates 27th Annual George Bailey Public Service Awards
Firm News | less than 1 min read | 04.21.26
Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | 3 min read | 04.21.26
